Patents by Inventor Camilla ENGBLOM

Camilla ENGBLOM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240080346
    Abstract: Provided herein are methods, compositions, and kits for the detection of immune cell clonotypes and immune cell analytes within a biological sample.
    Type: Application
    Filed: October 30, 2023
    Publication date: March 7, 2024
    Inventors: Camilla Engblom, Kim Thrane, Jeffrey Mold, Jonas Frisen, Joakim Lundeberg, Qirong Lin
  • Patent number: 11845979
    Abstract: Provided herein are methods, compositions, and kits for the detection of immune cell clonotypes and immune cell analytes within a biological sample.
    Type: Grant
    Filed: May 10, 2023
    Date of Patent: December 19, 2023
    Assignee: 10x Genomics, Inc.
    Inventors: Camilla Engblom, Kim Thrane, Jeffrey Mold, Jonas Frisen, Joakim Lundeberg, Qirong Lin
  • Publication number: 20230340577
    Abstract: Provided herein are methods, compositions, and kits for the detection of immune cell clonotypes and immune cell analytes within a biological sample.
    Type: Application
    Filed: May 10, 2023
    Publication date: October 26, 2023
    Inventors: Camilla Engblom, Kim Thrane, Jeffrey Mold, Jonas Frisen, Joakim Lundeberg, Qirong Lin
  • Patent number: 11692218
    Abstract: Provided herein are methods, compositions, and kits for the detection of immune cell clonotypes and immune cell analytes within a biological sample.
    Type: Grant
    Filed: December 15, 2021
    Date of Patent: July 4, 2023
    Assignee: 10x Genomics, Inc.
    Inventors: Camilla Engblom, Kim Thrane, Jeffrey Mold, Jonas Frisen, Joakim Lundeberg, Qirong Lin
  • Publication number: 20220106633
    Abstract: Provided herein are methods, compositions, and kits for the detection of immune cell clonotypes and immune cell analytes within a biological sample.
    Type: Application
    Filed: December 15, 2021
    Publication date: April 7, 2022
    Inventors: Camilla Engblom, Kim Thrane, Jeffrey Mold, Jonas Frisen, Joakim Lundeberg, Qirong Lin
  • Publication number: 20200132691
    Abstract: Described herein are methods and compositions for treating cancer. Aspects of the invention relate to administering to a subject an agent that inhibits the activity, level, and/or migration of a SiglecFhigh cell. Another aspect of the invention relates to first identifying a population of SiglecFhigh cells in a patient and then administering an agent to the patient that inhibits the activity, level, Sand/or migration of said population of SiglecFhigh cells. In one embodiment, the patient has lung cancer.
    Type: Application
    Filed: April 24, 2018
    Publication date: April 30, 2020
    Applicants: THE GENERAL HOSPITAL CORPORATION, PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Mikael PITTET, Camilla ENGBLOM, Christina PFIRSCHKE, Allon M KLEIN